Blind clinical trial device

Abstract

The present invention relates to a device for blinding the administration of nonsolid pharmaceutical presentations. The device is in particular an opaque container which has at least two attachments, one of which is intended for connection to a dispenser for the pharmaceutical presentation, and the other of which is intended for connection to an applicator, the inside of said container having means for holding back the pharmaceutical presentation.

What is claimed is:  
     
       1. An opaque container ( 1 ) for blinding the administration of nonsolid pharmaceutical presentations in clinical trials on mammals, which has at least two attachments, ( 2 ,  3 ), one of which is intended for connection to a dispenser for the pharmaceutical presentation, and the other of which is intended for connection to an applicator, the inside of said container ( 1 ) having means ( 4 ) for holding back the pharmaceutical presentation, wherein the attachment intended for connection to the applicator has a closure inside the container. 
     
     
       2. An opaque container ( 1 ) for blinding the administration of nonsolid pharmaceutical presentations in clinical trials on mammals, which has at least two attachments ( 2 , 3 ), one of which is intended for connection to a dispenser for the pharmaceutical presentation, and the other of which is intended for connection to an applicator, the attachments in the inside of the container having a continuous connection ( 5 ) ensuring that the pharmaceutical presentation is transported through the container ( 1 ). 
     
     
       3. An opaque container ( 1 ) for blinding the administration of nonsolid pharmaceutical presentations in clinical trials on mammals, which has at least three attachments ( 2 , 2 , 3 ), two of which are intended for connection to a dispenser for the pharmaceutical presentation, and the third one of which is intended for connection to an applicator, the inside of said container ( 1 ) having means ( 4 ) for holding back the pharmaceutical presentation, and one of the attachments ( 2 ) which are intended for connection to a dispenser has a continuous connection ( 5 ) to the attachment ( 3 ) which is intended for connection to the applicator, and the connection ensures that the pharmaceutical presentation is transported through the container ( 1 ). 
     
     
       4. A device for blinding the administration of nonsolid pharmaceutical presentations in clinical trials on mammals, comprising a container ( 1 ) as claimed in  claim 1 . 
     
     
       5. The device as claimed in  claim 4 , characterized in that the device moreover has a syringe and a catheter system intended for pulmonary administration. 
     
     
       6. The container ( 1 ) as claimed in  claim 1 , characterized in that the container ( 1 ) has an absorbent material inside it. 
     
     
       7. The container ( 1 ) as claimed in  claim 1 , characterized in that attachments ( 2 ,  3 ) are Luer lock attachments. 
     
     
       8. The container ( 1 ) as claimed in  claim 1 , characterized in that the container ( 1 ) is made of rubber or plastic. 
     
     
       9. The container as claimed in  claim 1 , characterized in that inside the container an inlet tube ( 19 ) connected to a nonreturn valve ( 28 ) is connected to a 1 st  attachment ( 29 ) of a Y-connector ( 32 ), which with its 2 nd  attachment ( 30 ) is sealingly connected to an outlet tube ( 22 ), and the outlet tube ( 22 ) is sealed inside the container, and at the 3rd attachment ( 31 ) of the Y-connector ( 32 ) there is an open cap ( 36 ) through which the pharmaceutical presentation can flow into the inside of the container. 
     
     
       10. The container as claimed in  claim 2 , characterized in that inside the container an inlet tube ( 19 ) connected to a nonreturn valve ( 28 ) is connected to a 1 st  attachment ( 29 ) of a Y-connector ( 32 ), which with its 2 nd  attachment ( 30 ) is sealingly connected to an outlet tube ( 33 ), and at the 3 rd  attachment ( 31 ) of the Y-connector ( 32 ) there is a sealed cap ( 41 ), and the outlet tube ( 33 ) is of open design. 
     
     
       11. A device for blinding the administration of nonsolid pharmaceutical presentations in clinical trials on mammals, comprising a container ( 1 ) as claimed in  claim 2 . 
     
     
       12. A device for blinding the administration of nonsolid pharmaceutical presentations in clinical trials on mammals, comprising a container ( 1 ) as claimed in  claim 3 . 
     
     
       13. The device as claimed in  claim 11 , characterized in that the device moreover has a syringe and a catheter system intended for pulmonary administration. 
     
     
       14. The device as claimed in  claim 12 , characterized in that the device moreover has a syringe and a catheter system intended for pulmonary administration. 
     
     
       15. The container ( 1 ) as claimed in  claim 2 , characterized in that the container ( 1 ) has an absorbent material inside it. 
     
     
       16. The container ( 1 ) as claimed in  claim 3 , characterized in that the container ( 1 ) has an absorbent material inside it. 
     
     
       17. The container ( 1 ) as claimed in  claim 2 , characterized in that attachments ( 2 ,  3 ) are Luer lock attachments. 
     
     
       18. The container ( 1 ) as claimed in  claim 3 , characterized in that attachments ( 2 ,  3 ) are Luer lock attachments. 
     
     
       19. The container ( 1 ) as claimed in  claim 2 , characterized in that the container ( 1 ) is made of rubber or plastic. 
     
     
       20. The container ( 1 ) as claimed in  claim 3 , characterized in that the container ( 1 ) is made of rubber or plastic.